A PHASE 2B STUDY OF TELAPREVIR WITH PEGINTERFERON-ALFA-2A AND RIBAVIRIN IN HEPATITIS C GENOTYPE 1 NULL AND PARTIAL RESPONDERS AND RELAPSERS FOLLOWING A PRIOR COURSE OF PEGINTERFERON-ALFA-2A/B AND RIBAVIRIN THERAPY: PROVE3 INTERIM RESULTS

Published

Conference Paper

Full Text

Duke Authors

Cited Authors

  • McHutchison, JG; Shiffman, ML; Terrault, N; Manns, MP; Di Bisceglie, AM; Jacobson, IM; Afdhal, NH; Heathcote, EJ; Zeuzem, S; Reesink, HW; George, S; Adda, N; Muir, AJ

Published Date

  • October 1, 2008

Published In

Volume / Issue

  • 48 / 4

Start / End Page

  • 431A - 432A

Published By

Pages

  • 2

International Standard Serial Number (ISSN)

  • 0270-9139

Conference Name

  • 59th Annual Meeting of the American-Association-for-the-Study-of-Liver-Diseases

Conference Location

  • San Francisco, CA

Conference Start Date

  • October 31, 2008

Conference End Date

  • November 4, 2008